Home  >  Speakers  >  Marc Steven Sabatine
Marc Steven Sabatine

Marc Steven Sabatine MD, MPH

Chair, Professor | Boston, Massachusetts    United States of America
Cardiology, Vascular Medicine,...More
Cardiology, Acute Coronary Syndromes,...More
Spoken at 30 events
Speaking at 4 events

Biography :

Dr. Marc S. Sabatine is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital (BWH) and holds the Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine. A cardiovascular specialist, he is also a professor of medicine at Harvard Medical School (HMS).

Dr. Sabatine received his medical degree from HMS and completed a residency in internal medicine at Massachusetts General Hospital (MGH). He then completed a clinical fellowship in cardiovascular disease at Massachusetts General Hospital and a fellowship in cardiovascular research at BWH. Dr. Sabatine is board certified in internal medicine and cardiovascular disease and is a fellow of the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.

His clinical interest is in acute coronary syndromes and critical care, and he attends the Cardiac Intensive Care Units at both BWH and MGH. His research interests include coronary artery disease, acute coronary syndromes, dyslipidemias, proteomics, and genomics. As the chairman of the TIMI Study Group, an academic research organization that has led major cardiovascular medicine clinical trials since its inception in 1984, Dr. Sabatine leads large-scale international randomized controlled trials testing novel therapies for cardiovascular care that have shaped the practice of medicine.

**********************
***** ********
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Cardiology, Vascular Medicine, Internal Medicine

Interested Topics

Cardiology, Acute Coronary Syndromes, Coronary Artery Disease, Genomics, Proteomics, Cardiac Intensive Care, Cardiovascular Diseases, Personalized Medicine, Dyslipidemias

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.

Appears with

MOC / CME / CE Requirements
Connecticut Medical Examining Board

Connecticut Medical Examining Board accepts the credit courses that are accredited by ACCME and awards AMA PRA Category 1 Credit.

MD/DO Requirement:

CME Credits Required : 50.00 | Licensing Cycle AMA PRA : 2 Years | Category Credits : 0.00

A minimum of 50 contact hours of qualifying continuing medical education every 2 years commencing on the first date of license renewal;1 contact hour means a minimum of 50 minutes of the continuing education activity once every 6 years.1 CME hour in each of the following topics:

(A) Infectious diseases, including, but not limited to, acquired immune deficiency syndrome and human immunodeficiency virus,
(B) risk management,
(C) sexual assault,
(D) domestic violence,
(E) cultural competency,
(F) behavioral health.

Beginning January 1, 2020, such behavioral health CME must include at least 2 contact hours on diagnosing and treating (i) cognitive conditions, including, but not limited to, Alzheimer’s disease, dementia, delirium, related cognitive impairments, and geriatric depression, or (ii) mental health conditions, including, but not limited to, those common to veterans and family members of veterans such as post-traumatic stress, risk of suicide, depression, and grief. OCC/MOC not accepted as a substitute. The commissioner may grant a waiver for not more than 10 contact hours of CME for physicians who:

(1) engage in activities related to the physician’s service as a member of the Connecticut Medical Examining Board,
(2) engage in activities related to the physician’s service as a member of a medical healing panel, or
(3) assist the state Department of Public Health with its duties to board and commissions (described in Ch. 368a. Sec. 10a-14).